J. Flynn

发表

Futuristic Methods for Determining HIV Co-receptor Use

J. Flynn, Matthew J. Gartner, Annamarie E. Laumaea, 2019, Global Virology III: Virology in the 21st Century.

Molecular Gymnastics: Mechanisms of HIV-1 Resistance to CCR5 Antagonists and Impact on Virus Phenotypes.

M. Churchill, S. Lewin, J. Flynn, 2015, Current topics in medicinal chemistry.

Differences in coreceptor specificity contribute to alternative tropism of HIV-1 subtype C for CD4+ T-cell subsets, including stem cell memory T-cells

M. Churchill, J. Flynn, P. Gorry, 2014, Retrovirology.

Assays for Inducing and Measuring Cell Death to Detect Macrophage Migration Inhibitory Factor (MIF) Release.

E. Morand, J. Flynn, S. Zamani, 2020, Methods in molecular biology.

Flow Cytometry Analysis to Identify Human CD8+ T Cells.

J. Flynn, P. Gorry, Jacqueline K. Flynn, 2019, Methods in molecular biology.

GILZ Regulates the Expression of Pro-Inflammatory Cytokines and Protects Against End-Organ Damage in a Model of Lupus

Md. Abul Hasnat, Linden J. Gearing, F. Vincent, 2021, Frontiers in Immunology.

Early IL‐10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users

J. Kaldor, M. Hellard, G. Dore, 2011, Journal of viral hepatitis.

Flow Cytometry Analysis to Identify Human CD4+ T Cell Subsets.

J. Flynn, P. Gorry, Jacqueline K. Flynn, 2019, Methods in molecular biology.

Quantifying Susceptibility of CD4+ Stem Memory T-Cells to Infection by Laboratory Adapted and Clinical HIV-1 Strains

M. Churchill, J. Flynn, P. Gorry, 2014, Viruses.

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users

M. Hellard, C. Aitken, J. Flynn, 2014, Hepatitis monthly.

Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc

M. Churchill, J. Flynn, P. Gorry, 2016, Retrovirology.

GILZ regulates type I interferon release and sequesters STAT1.

E. Morand, J. Flynn, James Harris, 2022, Journal of autoimmunity.

Maintenance of Th1 hepatitis C virus (HCV)‐specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment

J. Kaldor, M. Hellard, G. Dore, 2013, Journal of gastroenterology and hepatology.

The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets.

M. Churchill, S. Lewin, D. Purcell, 2013, Virology.

Flow Cytometry Phenotyping of Bone Marrow-Derived Macrophages from Wild-Type and Mif-/- Mice.

J. Flynn, Nadia S. Deen, James Harris, 2020, Methods in molecular biology.

Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts.

J. Kaldor, M. Hellard, G. Dore, 2012, The Journal of infectious diseases.

A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations

Brendan L Wilkinson, M. Churchill, S. Lewin, 2013, Retrovirology.

Role of Macrophages in the Immunopathogenesis of HIV-1 Infection

J. Flynn, P. Gorry, Jacqueline K. Flynn, 2015 .

Stem memory T cells (TSCM)—their role in cancer and HIV immunotherapies

J. Flynn, P. Gorry, Jacqueline K. Flynn, 2014, Clinical & translational immunology.

Understanding the mechanisms driving the spread of subtype C HIV-1

M. Churchill, J. Flynn, Matthew J. Gartner, 2020, EBioMedicine.

Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIV

M. Churchill, S. Lewin, J. Flynn, 2022, AIDS.

Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?

E. Morand, J. Flynn, W. Dankers, 2019, Front. Immunol..

Longitudinal analysis of subtype C envelope tropism for memory CD4+ T cell subsets over the first 3 years of untreated HIV-1 infection

M. Churchill, S. Lewin, P. Moore, 2020, Retrovirology.

Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy.

J. Flynn, S. Stacker, M. Smyth, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Is the central nervous system a reservoir of HIV-1?

M. Churchill, S. Wesselingh, J. Flynn, 2014, Current opinion in HIV and AIDS.

Necrotic cell death increases the release of macrophage migration inhibitory factor by monocytes/macrophages

Md. Abul Hasnat, E. Morand, J. Flynn, 2020, Immunology and cell biology.

Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancer.

J. Flynn, M. Smyth, P. Darcy, 2012, Cancer research.

Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 Antagonists.

M. Churchill, S. Lewin, J. Flynn, 2017, AIDS research and human retroviruses.

Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc

M. Churchill, J. Flynn, P. Gorry, 2016, Retrovirology.

Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection

H. Ullum, M. Churchill, D. Purcell, 2013, PloS one.